In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer

In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer

ABSTRACT: Objectives: Gram-negative bacilli (GNB) are currently the predominant bacterial pathogens in patients with cancer. Many GNB have become problematic due to the widespread emergence of resistance. Imipenem/relebactam (IMI/REL) is a combination of the carbapenem imipenem with relebactam, a n...

Full description

Bibliographic Details
Main Authors: Kenneth V.I. Rolston, Bahgat Z. Gerges, Ruth Reitzel, Samuel A. Shelburne, Samuel L. Aitken, Issam I. Raad, Randall A. Prince
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Gram-negative isolates
Patients with cancer
Imipenem/relebactam
In vitro
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522000261

Internet

http://www.sciencedirect.com/science/article/pii/S2213716522000261

Similar Items